Issued Patents All Time
Showing 25 most recent of 44 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415809 | Pyrrolotriazine compounds as tam inhibitors | Yun-Long Li, Joseph Barbosa, David M. Burns, Hao Feng, Joseph Glenn +4 more | 2025-09-16 |
| 12378243 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more | 2025-08-05 |
| 12331063 | Hetero-bicyclic inhibitors of KRAS | Alexander Sokolsky, Chang Min, Wenqing Yao | 2025-06-17 |
| 12077539 | Imidazole and triazole KRAS inhibitors | Chao Qi, Wenqing Yao | 2024-09-03 |
| 12060433 | CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy | Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more | 2024-08-13 |
| 12030884 | Pyrazoloquinoline KRAS inhibitors | Wenyu Zhu, Wenqing Yao | 2024-07-09 |
| 12030883 | Hetero-tricyclic compounds as inhibitors of KRAS | Peter Carlsen, Ken Mukai, Haolin Yin, Wenqing Yao, Wenyu Zhu | 2024-07-09 |
| 11999752 | Vinyl imidazole compounds as inhibitors of KRAS | Peter Carlsen, Alexander Sokolsky, Pei Gan, Rocco Policarpo, Wenqing Yao | 2024-06-04 |
| 11999740 | Fused pyrazine derivatives as A2A / A2B inhibitors | Peter Carlsen, Pei Gan, Gia Hoang, Yong Li, Chao Qi +3 more | 2024-06-04 |
| 11976073 | Bicyclic amines as CDK2 inhibitors | Joshua Hummel, David M. Burns, Ding-Quan Qian | 2024-05-07 |
| 11939328 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Artem Shvartsbart, Wenyu Zhu, Bin Hu +3 more | 2024-03-26 |
| 11884665 | Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors | Taisheng Huang | 2024-01-30 |
| 11873304 | Fused pyrimidine derivatives as A2A/A2B inhibitors | Heeoon Han, Matthew S. McCammant, Liangxing Wu, Wenqing Yao, Zhiyong Yu +1 more | 2024-01-16 |
| 11767320 | Bicyclic dione compounds as inhibitors of KRAS | Taisheng Huang, Wenqing Yao | 2023-09-26 |
| 11739102 | Fused pyrimidine compounds as KRAS inhibitors | Gia Hoang, Wenqing Yao | 2023-08-29 |
| 11673894 | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors | Pei Gan, Taisheng Huang, Chao Qi, Ding-Quan Qian, Liangxing Wu +5 more | 2023-06-13 |
| 11591338 | Pyrrolotriazine compounds as TAM inhibitors | Yun-Long Li, Chunhong He | 2023-02-28 |
| 11530218 | Spiro compounds as inhibitors of KRAS | Le Zhao, Wenyu Zhu, Haolin Yin, Liangxing Wu, Wenqing Yao | 2022-12-20 |
| 11390624 | Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors | Taisheng Huang | 2022-07-19 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Chunhong He, Wenqing Yao, Fenglei Zhang | 2022-02-15 |
| 11220510 | Pyrrole tricyclic compounds as A2A / A2B inhibitors | Peter Carlsen, Chunhong He, Taisheng Huang | 2022-01-11 |
| 11168089 | Fused pyrimidine derivatives as A2A / A2B inhibitors | Heeoon Han, Matthew S. McCammant, Liangxing Wu, Wenqing Yao, Zhiyong Yu +1 more | 2021-11-09 |
| 11161850 | Fused pyrazine derivatives as A2A / A2B inhibitors | Yong Li, Chao Qi, Liangxing Wu, Wenqing Yao, Wenyu Zhu | 2021-11-02 |
| 11136326 | Pyrrolopyrimidine derivatives as TAM inhibitors | Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He +3 more | 2021-10-05 |
| 10968221 | Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors | Liangxing Wu, Wenqing Yao, Colin Zhang | 2021-04-06 |